Get access

One-Pot Reactions Accelerate the Synthesis of Active Pharmaceutical Ingredients

Authors


  • We thank the Fonds der Chemischen Industrie for financial support (Dozentenstipendium to M.C. and Chemiefonds-Stipendium to P.W.).

Abstract

original image

All in one: A one-pot synthesis of the dipeptidylpeptidase IV selective inhibitor ABT-341 (see structure) by using an “uninterrupted sequence of reactions” has been developed. This strategy broadens the spectrum of one-pot reactions and is poised to speed up the synthesis of medicinally relevant drug compounds.

Ancillary